16-mer a 6-carboxyfluorescein (6-FAM) used for oligonucleotide labeling at 5'-end b primer sequences in template are underlined c template biotinylated at 5'-end d template labeled by ortho-TINA at 5'-end Figure S1 . Primer extension experiments in the presence of Vent (exo-) or Bst LF DNA polymerase using temp oligo1A . Lanes 1, P: primer; lanes 2, +: products of PEX with natural dNTPs; lanes 3, A-: products of PEX with dTTP, dCTP and dGTP; lanes 4-9, R A: product of PEX with dTTP, dCTP, dGTP and functionalized d R ATP. Figure S2 . Primer extension experiments in the presence of Vent (exo-) or Bst LF DNA polymerase using temp Prb4basII -TINA. Lanes 1, P: primer; lanes 2, +: products of PEX with natural dNTPs; lanes 3, A-: products of PEX with dTTP, dCTP and dGTP; lanes 4-9, R A: product of PEX with dTTP, dCTP, dGTP and functionalized d R ATP. Figure S5 . Denaturating PAGE showing results of a thiol-ene or CuAAC reaction of starting vinyl-or ethynyl-modified dsDNA (DNA1 V A or DNA1 E A) containing one modification in the sequence. Lanes 1 and 5 P: primer; lanes 2 and 6 R A: products of analytical PEX with dGTP and functionalized d R ATP; lanes 3 and 7 ON1 R A: products of semi-preparative PEX with dGTP and functionalized d R ATP; lanes 4 and 8, ON1 X A: products of thiol-ene or CuAAC reaction respectively.
S6

Experimental part
Chemical synthesis
Materials and methods
Reagents and solvents were purchased from Sigma-Aldrich and AlfaAesar. 2,6-Dichloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-ribofuranosyl]-purine S1 and 2-iodo-2'-deoxyadenosine d I A were prepared as described previously. S1,S2 The reactions were monitored by thin-layer chromatography using Merck silica gel 60 F254 plates and visualized by UV (254 nm). Column chromatography was performed using silica gel (40-63 µm). Reversedphase high-performance flash chromatography (HPFC) purifications were done on a Biotage SP1 apparatus with C-18 columns. Purification of nucleoside triphosphates was performed using HPLC (Waters modular HPLC system) on a column packed with 10 μm C18 reversed phase (Phenomenex, Luna C18 (2) 100 Å). NMR spectra were measured on a Bruker AVANCE 500 ( 1 H at 500.0 MHz, 13 C at 125.7 MHz and 31 P at 202.3 MHz) and Bruker AVANCE 600 ( 1 H at 600.1 MHz and 13 C at 150.9 MHz) NMR spectrometers in CDCl3, DMSO-d6 or D2O solutions at 25 °C. Chemical shifts (in ppm, δ scale) were referenced to the residual solvent signal in 1 H spectra (δ(CHCl3) = 7.26 ppm, δ((CHD2)SO(CD3)) = 2.5 ppm) or to the solvent signal in 13 C spectra (δ(CDCl3) = 77.0 ppm, δ((CD3)2SO) = 39.7 ppm). 1,4-Dioxane was used as an internal standard for D2O solutions (3.75 ppm for 1 H and 69.3 ppm for 13 C). Coupling constants (J) are given in Hz. The complete assignment of 1 H and 13 C signals was performed by an analysis of the correlated homonuclear H,H-COSY, and heteronuclear H,C-HSQC and H,C-HMBC spectra. High resolution mass spectra were measured on a LTQ Orbitrap XL spectrometer (Thermo Fisher Scientific).
2-Chloro-2'-deoxyadenosine; Cladribine (d Cl A)
2-Chloro-2'-deoxyadenosine d Cl A was prepared according to a literature procedure with minor modifications. S1 Protected nucleoside S1 (700 mg, 1.29 mmol) was dissolved in MeOH saturated with ammonia (20 ml) and heated to 110 °C for 5 h in a sealed pressure tube. After cooling the solvent was evaporated. The residue was dissolved in MeOH, coevaporated with silica gel and purified by column chromatography (5% → 10% MeOH in CH2Cl2). The title compound was obtained as a white solid (318 mg, 86%). Rf: 0.40 (20% MeOH in CH2Cl2). 1 H NMR (500.0 MHz, DMSO-d6): 2.28 (ddd, 1H, Jgem = 13.2, J2′b,1′ = 6.2, J2′b,3′ = 3.3, H-2′b); 2.65 (ddd, 1H, Jgem = 13.2, J2′a,1′ = 7.6, J2′a,3′ = 5.8, H-2′a); 3.51 (ddd, 1H, Jgem = 11.8, J5′b, OH = 6.0, J5′b, 4′ = 4.5, 3.60 (ddd, 1H, Jgem = 11.8, J5′a, OH = 5.1, J5′a, 4′ = 4.5, 3.86 (td, 1H, J4′, 5′ = 4.5, 4.1, J4′, 3′ = 2.8, 4.39 (dddd, 1H, J3′, 2′ = 5.8, 3.3 
2,6-Diazido-9-(2'-deoxy-β-D-ribofuranosyl)purine (S2)
Protected nucleoside S1 (409 mg, 0.74 mmol) was dissolved in EtOH/H2O = 9/1 mixture (20 ml). To the resulting solution, NaN3 (110 mg, 1.70 mmol) was added and reaction mixture was refluxed for 30 min. After cooling the solvent was evaporated and the residue was dissolved in CHCl3 (30 ml) and washed with H2O (3x30 ml). The organic layer was dried over anhydrous Na2SO4 and concentrated on a rotavap. Obtained product (400 mg, 98%) was used in the next step without further purification. Rf: 0.31 (30% EtOAc in n-hexane 
2,6-Diamino-9-(2'-deoxy-β-D-ribofuranosyl)purine (S3)
2,6-Diazido-9-(2'-deoxy-β-D-ribofuranosyl)purine S2 (400 mg, 0.72 mmol) was dissolved in EtOH/DMA = 2/1 mixture (24 ml) and 10% palladium on charcoal was added (40 mg). The reaction mixture was then purge-and-refilled with H2 4 times. Reaction mixture was stirred at room temperature for 24 h; then it was filtered through a pad of Celite and evaporated to dryness. The residue was purified by column chromatography (0% → 3% MeOH in CH2Cl2) to give the desired product (348 mg, 96%) as a white solid. Rf: 0.25 (2% MeOH in CH2Cl2).
1 H NMR (500.0 MHz, CDCl3): 2.39, 2.43 (2 × s, 2 × 3H, CH3-Tol); 2.70 (ddd, 1H, Jgem = 14.2, J2′b,1′ = 5.9, J2′b,3′ = 2.0, H-2′b); 3.10 (ddd, 1H, Jgem = 14.2, J2′a,1′ = 8.5, J2′a,3′ = 6.2, H-2′a); 4.63 (ddd, 1H, J4′,5′ = 4.7, 4.4, J4′,3′ = 2.0, H-4′); 4.65 (dd, 1H, Jgem = 11.7, J5′b, 4′ = 4.7, 
2-Amino-2'-deoxyadenosine (d NH2 A)
Protected nucleoside S3 (320 mg, 0.64 mmol) was dissolved in MeOH and K2CO3 (264 mg, 1.91 mmol) was added. Resulting solution was stirred at room temperature for 1 h. The reaction mixture was filtered and coevaporated with silica gel. The title compound, obtained after column chromatography (5% → 15% MeOH in CH2Cl2), was obtained as a white solid (162 mg, 96%). NMR data were in agreement with those reported previously. 
2-Methyl-2'-deoxyadenosine (d Me A)
2-Iodo-2'-deoxyadenosine d I A (100 mg, 0.27 mmol) and (NH4)2SO4 (4 mg, 10 mol %) were dissolved in HMDS (2 ml) and the resulting solution was stirred at 40 °C for 20 minutes. Solvent was evaporated; the residue was dissolved in anhydrous THF (2 ml) and the flask was flushed with argon. To this Pd(PPh3)4 (31 mg, 10 mol %) dissolved in THF (0.5 ml) was added via syringe. Me3Al (0.33 ml, 0.66 mmol, 2M in toluene) was added dropwise. Reaction mixture was stirred at 60 °C for 2 h. After cooling the reaction mixture was carefully quenched with MeOH and evaporated to dryness. The residue was dissolved in MeOH and coevaporated with silica gel. The desired product was purified by column chromatography (0% → 8% MeOH in CH2Cl2) and further purified by RP-HPFC on C-18 (0% → 100% MeOH in H2O) affording a white solid (49 mg, 70%).
1 H NMR were in agreement with those reported previously. S4 Rf: 0.18 (10% MeOH in CH2Cl2).
1 H NMR (500.0 MHz, DMSO-d6): 2.21 (ddd, 1H, Jgem = 13.1, J2′b,1′ = 5.9, J2′b,3′ = 2.4, H-2′b); 2.37 (s, 3H, CH3); 2.69 (ddd, 1H, Jgem = 13.1, J2′a,1′ = 8.4, J2′a,3′ = 5.5, H-2′a); 3.53 (ddd, 1H, Jgem = 11.8, J5′b,OH = 7.5, J5′b,4′ = 3.8, H-5′b); 3.63 (dt, 1H, Jgem = 11.8, J5′a,4′ = J5′a,OH = 3.8, H-5′a); 3.89 (td, 1H, J4′,5′ = 3.8, J4′,3′ = 2.1, H-4′); 4.37 -4.44 (bm, 1H, H-3′); 5.32 (bd, 1H, JOH,3′ = 3.0, OH-3′); 5.59 (bdd, 1H, JOH,5′ = 7.5, 3.8, OH-5′); 6.31 (dd, 1H, J1′,2′ = 8.4, 5.9, H-1′); 7.25 (bs, 2H, NH2); 8.24 (s, 1H, H-8).
13 C NMR (125. 
2-Phenyl-2'-deoxyadenosine (d Ph A)
A flask containing 2-iodo-2'-deoxyadenosine d I A (100 mg, 0.27 mmol), PhB(OH)2 (48 mg, 0.40 mmol), Cs2CO3 (259 mg, 0.80 mmol), Pd(OAc)2 (3 mg, 5 mol %) and TPPTS (19 mg, 12.5 mol %) was filled with argon and H2O/MeCN = 2/1 mixture (3.3 ml) was added. The reaction mixture was stirred at 80 °C until complete consumption of starting material was observed according to TLC (ca 1.5 h). After cooling the solvent was evaporated. The residue was dissolved in MeOH, coevaporated with silica gel and purified by column chromatography (0% → 10% MeOH in CH2Cl2) to afford the desired nucleoside as a white solid (79 mg, 91%). Rf: 0.27 (10% MeOH in CH2Cl2).
1 H NMR (500.0 MHz, DMSO-d6): 2.32 (ddd, 1H, Jgem = 13.3, J2′b,1′ = 6.2, J2′b,3′ = 3.1, H-2′b); 2.84 (ddd, 1H, Jgem = 13.3, J2′a,1′ = 7.7, J2′a,3′ = 5.8, H-2′a); 3.54 (ddd, 1H, Jgem = 11.6, J5′b,OH = 5.7, J5′b,4′ = 4.8, H-5′b); 3.64 (dt, 1H, Jgem = 11.6, J5′a,OH = 5.4, J5′a,4′ = 4.8, H-5′a); 3.89 (td, 1H, J4′,5′ = 4.8, J4′,3′ = 2. 
2-Vinyl-2'-deoxyadenosine (d V A)
A flask containing 2-iodo-2'-deoxyadenosine d I A (100 mg, 0.27 mmol), potassium vinyltrifluoroborate (53 mg, 0.40 mmol), Cs2CO3 (259 mg, 0.80 mmol), Pd(OAc)2 (3 mg, 5 mol %) and TPPTS (19 mg, 12.5 mol %) was filled with argon and H2O/MeCN = 2/1 mixture (3.3 ml) was added. The reaction mixture was stirred at 80 °C until complete consumption of starting material was observed according to TLC (ca 2.5 h). Solvent was evaporated and the residue was coevaporated with MeOH and silica gel. The title compound was obtained, after column chromatography purification (0% → 5% MeOH in CH2Cl2), as a white solid (59 mg, 80%). NMR data were in agreement with those reported previously. 
2-Ethynyl-2'-deoxyadenosine (d E A)
2-Ethynyl-2'-deoxyadenosine d E A was prepared according to the literature procedure with minor modifications.
S2
Dry DMF (2.8 ml) was added to a flask containing 2-Iodo-2'-deoxyadenosine d I A (150 mg, 0.40 mmol), PdCl2(PPh3)2 (28 mg, 10 mol %) and CuI (8 mg, 10 mol %) and the resulting mixture was purge-and-refilled with argon 3 times. Trimethylsilylacetylene (84 μl, 0.60 mmol) and Et3N (110 μl, 0.80 mmol) were added via syringe and the mixture was stirred at room temperature until the complete consumption of the starting nucleoside was observed by TLC (ca 3 hours). Then the reaction mixture was filtered through a pad of Celite and evaporated on a rotavap. The residue was dissolved in MeOH (5 ml) and K2CO3 (82 mg, 0.60 mmol) was added. The reaction mixture was stirred at room temperature for 1.5 hours and filtered. The residue was coevaporated with silica gel and purified by column chromatography (0% → 10% MeOH in CH2Cl2) and further purified by RP-HPFC on C-18 (0% → 100% MeOH in H2O). The title compound was obtained as a white solid (86 mg, 79% over two steps). Rf: 0.36 (10% MeOH in CH2Cl2).
1 H NMR (500.0 MHz, DMSO-d6): 2.27 (ddd, 1H, Jgem = 13.2, J2′b,1′ = 6.1, J2′b,3′ = 3.1, H-2′b); 2.67 (ddd, 1H, Jgem = 13.2, J2′a,1′ = 7.7, J2′a,3′ = 5.8, H-2′a); 3.51 (ddd, 1H, Jgem = 11.8, J5′b,OH = 6.3, J5′b,4′ = 4.4, H-5′b); 3.60 (ddd, 1H, Jgem = 11.8, J5′a,OH = 5.2, J5′a,4′ = 4.4, H-5′a); 3.86 (td, 1H, J4′,5′ = 4.4, J4′,3′ = 2.7, H-4′); 4.02 (s, 1H, HC≡C-) 
2-Chloro-2'-deoxyadenosine-5'-O-triphosphate (d Cl ATP)
Starting 2-chloro-2'-deoxyadenosine d Cl A (35 mg, 0.123 mmol) was dried in vacuo overnight.
Then it was dissolved in dry PO(OMe)3 (1.4 ml) and cooled down to 0 °C. Freshly distilled POCl3 (14 μl, 0.147 mmol) was added dropwise and reaction mixture was stirred at 0 °C until no more starting material could be observed by TLC (ca 3 hours). Then an ice-cold solution of (n-Bu3NH)2H2P2O7 (336 mg, 0.613 mmol) and n-Bu3N (128 µl, 0.490 mmol) in dry DMF (0.9 ml) was added dropwise. The reaction mixture was stirred for another 1 hour at 0 ºC and then quenched by the addition of cold 1M TEAB (0.9 ml). The mixture was concentrated on a rotavap; the residue was co-evaporated with distilled water three times. The crude product was dissolved in water (ca 3 ml); the aqueous solution was purified by semi-preparative HPLC using a linear gradient of methanol (5→100%) in 0.1 M TEAB buffer. The appropriate fractions were combined and evaporated on a rotavap. The viscous oil was coevaporated with distilled water three times. The product was converted to sodium salt on an ion-exchange column (Dowex 50WX8 in Na + cycle) and freeze-dried. The title compound was obtained as white solid (45 mg, 60%). NMR data were in agreement with those reported previously.
S6 1 H NMR (500.0 MHz, D2O): 2.63 (ddd, 1H, Jgem = 14.0, J2′b,1′ = 6.3, J2′b,3′ = 3.6, H-2′b); 2.79 (ddd, 1H, Jgem = 14.0, J2′a,1′ = 7.3, J2′a,3′ = 6.1, H-2′a); 4.16 (ddd, 1H, Jgem = 11.5, JH,P = 5.1, J5′b,4′ = 3.6, H-5′b); 4.22 (ddd, 1H, Jgem = 11.5, JH,P = 6.2, J5′a,4′ = 3.6, H-5′a); 4.31 (qd, 1H, J4′,3′ = J4′,5′ = 3.6, JH,P = 1.9, H-4′); 4.80 (dt, 1H, J3′,2′ = 6.1, 3.6, J3′,4′ = 3.6, H-3′); 6.36 (dd, 1H, J1′,2′ = 7.3, 6.3, H-1′) 
2-Amino-2'-deoxyadenosine-5'-O-triphosphate (d NH2 ATP)
2-Amino-2'-deoxyadenosine-5'-O-triphosphate d NH2 ATP was prepared from nucleoside d NH2 A (32 mg, 0.119 mmol), following the procedure described for preparation of d Cl ATP, as a white solid (13 mg, 18%).
1 H NMR (500.0 MHz, D2O): 2.51 (ddd, 1H, Jgem = 14.0, J2′b,1′ = 6.3, J2′b,3′ = 3.3, H-2′b); 2.77 (ddd, 1H, Jgem = 14.0, J2′a,1′ = 7.7, J2′a,3′ = 6.1, H-2′a); 4.14 (ddd, 1H, Jgem = 11.4, JH,P = 5.2, J5′b,4′ = 3.7, H-5′b); 4.20 (ddd, 1H, Jgem = 11.4, JH,P = 6.2, J5′a,4′ = 3.7, H-5′a); 4.26 (qd, 1H, J4′,3′ = J4′,5′ = 3.7, JH,P = 1.8, H-4′); 4.78 (ddd, 1H, J3′,2′ = 6.1, 3.3, J3′,4′ = 3.7, H-3′); 6.33 (dd, 1H, J1′,2′ = 7.7, 6.3, H-1′); 8.16 (s, 1H, H-8).
2-Methyl-2'-deoxyadenosine-5'-O-triphosphate (d Me ATP)
2-Methyl-2'-deoxyadenosine-5'-O-triphosphate d Me ATP was prepared from nucleoside d Me A (10 mg, 0.038 mmol), following the procedure described for preparation of d Cl ATP, as a white solid (5.2 mg, 23%). 1 H NMR (500.0 MHz, D2O): 2.52 (s, 3H, CH3); 2.57 (ddd, 1H, Jgem = 14.0, J2′b,1′ = 6.3, J2′b,3′ = 3.7, H-2′b); 2.79 (ddd, 1H, Jgem = 14.0, J2′a,1′ = 7.3, J2′a,3′ = 6.2, H-2′a); 4.14 (ddd, 1H, Jgem = 11.5, JH,P = 5.0, J5′b,4′ = 3.7, H-5′b); 4.23 (ddd, 1H, Jgem = 11.5, JH,P = 6.2, J5′a,4′ = 3.7, H-5′a); 4.28 (qd, 1H, J4′,3′ = J4′,5′ = 3.7, JH,P = 1.9, H-4′); 4.80 (dt, 1H, J3′,2′ = 6.2, 3.7, J3′,4′ = 3.7, H-3′); 6.48 (dd, 1H, J1′,2′ = 7.3, 6.3, H-1′); 8.43 (s, 1H, H-8). 
2-Phenyl-2'-deoxyadenosine-5'-O-triphosphate (d Ph ATP)
2-Phenyl-2'-deoxyadenosine-5'-O-triphosphate d Ph ATP was prepared from nucleoside d Ph A (28 mg, 0.086 mmol), following the procedure described for preparation of d Cl ATP, as a white solid (13.2 mg, 24%).
1 H NMR (600.0 MHz, D2O): 2.60 (ddd, 1H, Jgem = 14.0, J2′b,1′ = 6.5, J2′b,3′ = 3.7, H-2′b); 2.86 (ddd, 1H, Jgem = 14.0, J2′a,1′ = 7.3, J2′a,3′ = 6.2, H-2′a); 4.19 (ddd, 1H, Jgem = 11.5, JH,P = 5.2, J5′b,4′ = 3.7, H-5′b); 4.25 (ddd, 1H, Jgem = 11.5, JH,P = 6.3, J5′a,4′ = 3.7, H-5′a); 4.31 (qd, 1H, J4′,3′ = J4′,5′ = 3.7, JH,P = 1.6, H-4′); 4.85 (dt, 1H, J3′,2′ = 6.2, 3.7, J3′,4′ = 3.7, H-3′); 6.63 (dd, 1H, J1′,2′ = 7.3, 6.5, H-1′); 7.51 -7.59 (m, 3H, H-m,p-Ph); 8.09 -8.15 (m, 2H, H-oPh); 8.49 (s, 1H, H-8). 
2-Vinyl-2'-deoxyadenosine-5'-O-triphosphate (d V ATP)
Starting 2-vinyl-2'-deoxyadenosine d V A (23.5 mg, 0.085 mmol) and proton sponge (22 mg, 0.102 mmol) were dried in vacuo overnight. Then dry PO(OMe)3 (1.0 ml) was added and the resulting solution was cooled down to 0 °C. Freshly distilled POCl3 (9 μl, 0.102 mmol) was added dropwise and reaction mixture was stirred at 0 °C until no more starting material could be observed by TLC (ca 3 hours). Then an ice-cold solution of (n-Bu3NH)2H2P2O7 (233 mg, 0.424 mmol) and n-Bu3N (89 µl, 0.339 mmol) in dry DMF (0.6 ml) was added dropwise. The reaction mixture was stirred for another 1 hour at 0 ºC and then quenched by the addition of cold 1M TEAB (0.6 ml). The mixture was concentrated on a rotavap; the residue was co-evaporated with distilled water three times. The crude product was dissolved in water (ca 3 ml); the aqueous solution was purified by semi-preparative HPLC using a linear gradient of methanol (5→100%) in 0.1 M TEAB buffer. The appropriate fractions were combined and evaporated on a rotavap. The viscous oil was coevaporated with distilled water three times. The S14 product was converted to sodium salt on an ion-exchange column (Dowex 50WX8 in Na + cycle) and freeze-dried. The title compound was obtained as white solid (11.5 mg, 22%).
1 H NMR (500.0 MHz, D2O): 2.59 (ddd, 1H, Jgem = 14.0, J2′b,1′ = 6.4, J2′b,3′ = 3.7, H-2′b); 2.83 (ddd, 1H, Jgem = 14.0, J2′a,1′ = 7.4, J2′a,3′ = 6.0, H-2′a); 4.16 (ddd, 1H, Jgem = 11.8, JH,P = 5.2, J5′b,4′ = 3.7, H-5′b); 4.24 (ddd, 1H, Jgem = 11.8, JH,P = 6.4, J5′a,4′ = 3.7, H-5′a); 4.29 (qd, 1H, J4′,3′ = J4′,5′ = 3.7, JH,P = 1.6, H-4′); 4.83 (dt, 1H, J3′,2′ = 6.0, 3.7, J3′,4′ = 3.7 
S15
Enzymatic synthesis and characterization of modified DNA
Materials and methods
Oligonucleotides were purchased from Generi Biotech (Czech Republic). Bst DNA polymerase Large Fragment, Vent (exo-) DNA polymerase and corresponding reaction buffers, as well as natural nucleoside triphosphates (dATP, dCTP, dGTP, dTTP), were purchased from New England Biolabs. KOD XL DNA polymerase and corresponding reaction buffer were obtained from Merck Millipore. Streptavidin magnetic beads were obtained from Roche. All solutions for biochemical reactions were prepared using Milli-Q water. The gels were visualized by a fluorescence scanner (Typhoon FLA 9500, GE Healthcare). Concentration of DNA solutions was calculated using A260 values measured on a Nanodrop and values obtained with OligoCalc. S7 Mass spectra of oligonucleotides were measured by MALDI-TOF, on UltrafleXtreme MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, Germany), with 1 kHz smartbeam II laser.
Analytical primer extension
Single incorporation of modified d R ATPs
Reaction mixture (20 μl) was prepared by mixing primer prim 248short -FAM (3 μM, 1 μl), template temp oligo1A (3 μM, 1. were subjected to vertical electrophoresis in 12.5% denaturing polyacrylamide gel containing 1TBE buffer (pH 8.0) and 7 M urea at 42 mA for 1 hour. The gel was visualized by a fluorescent scanner.
Multiple incorporations of modified d R ATPs
Reaction mixture (20 μl) contained primer prim 248short -FAM (3 μM, 1 μl), template temp Prb4basII -TINA (3 μM, 1.5 μl), DNA polymerase (0.125 -1.25 U KOD XL, 0.2 -0.4 U Vent (exo-), or 0.4 U Bst Large Fragment), natural dNTPs (4 mM, 1 μl), either natural or modified dATP (4 mM, 1.0 -2.5 μl depending on the modification) and reaction buffer (10, 2 μl). The reaction was incubated at 60 °C for 60 min. The reaction was stopped by addition of PAGE stop solution (40 μl; 80% [v/v] formamide, 20 mM EDTA, 0.025% [w/v] bromophenol blue, 0.025% [w/v] xylene cyanol) and heated at 95 °C for 5 min. Aliquots (5 μl) were subjected to vertical electrophoresis in 12.5% denaturing polyacrylamide gel containing 1TBE buffer (pH 8.0) and 7 M urea at 42 mA for 1 hour. The gel was visualized by a fluorescent scanner.
Kinetic study of incorporation of modified d R ATPs
PEX reaction mixtures (30 μl) containing KOD XL DNA polymerase (0.5 U), primer prim 248short -FAM (3 μM, 1.5 μl), template temp 1A_term (3μM, 2.25 μl), natural or modified dATPs (4 mM, 1 μl) and KOD XL reaction buffer (10, 3 μl) were incubated at 60 °C for specific time intervals (0.1 -5 minutes) and then the reaction was stopped by the addition of PAGE stop solution and immediate heating. Aliquots (5 μl) were subjected to vertical electrophoresis in 12.5% denaturing polyacrylamide gel containing 1TBE buffer (pH 8.0) and 7 M urea at 42 mA for 1 hour. The gel was visualized by a fluorescent scanner.
Semi-preparative primer extension with magnetic separation
Reaction mixture (50 μl) contained KOD XL DNA polymerase (0.25 -1.25 U), primer prim 248short (100 μM, 1.6 μl), 5'-biotinylated template (100 μM, 1.6 μl, for sequences see Table  S1 ), natural or modified dNTPs (dTTP, dCTP, dGTP and d R ATP, 4 mM each, 2.6 μl) and KOD XL reaction buffer (10, 5 μl). The reaction mixture was incubated for 40 min at 60 °C in a thermal cycler and the reaction was stopped by cooling to 4 °C. Streptavidine magnetic particles (Roche, 50 μl) were washed with binding buffer (3  200 μl, 10 mM Tris, 1 mM EDTA, 100 mM NaCl, pH 7.5). Then PEX solution (50 μl) and binding buffer (50 μl) were added to the magnetic beads. The mixture was incubated for 30 min at 15 °C and 1100 rpm. The magnetic beads were collected on a magnet (DynaMagTM-2, Invitrogen) and washed with washing buffer (3  200 μl, 10 mM Tris, 1 mM EDTA, 500 mM NaCl, pH 7.5) and water (4  200 μl). Then water (50 μl) was added and the sample was denatured for 2 min at 50 °C and 900 rpm. The beads were collected on a magnet and the solution was transferred into a clean vial and analyzed by MALDI-TOF MS (for copies of mass spectra see Figures S5-S14 ).
Semi-preparative preparation of modified DNA
Reaction mixture (250 μl) contained KOD XL DNA polymerase (2.5 U), primer prim 248short (100 μM, 10 μl), template (100 μM, 10 μl, for sequences see Table S1 ), natural dNTPs (dTTP, dGTP, dCTP, 4mM each, 5 μl), modified d R ATPs (4mM, 5 μl) and reaction buffer for KOD XL DNA polymerase (10, 25 μl). Reaction mixture was incubated at 60 °C for 40 min (70 °C for 60 min for temp Prb4basII ) in a thermoblock and stopped by cooling to 4 °C. dsDNA was purified with a QIAquick nucleotide removal kit (QIAGEN); reaction mixture was divided into two columns. Product was eluted with 100 μl of H2O and concentration was determined using NanoDrop and values obtained from OligoCalc.
S7
Natural DNA for control experiments was prepared following the same procedure using natural dATP instead of modified d R ATPs.
S17
Post-synthetic modification of DNA
Materials and methods
The oligonucleotides for these experiments were prepared by PEX on a large scale with KOD XL DNA polymerase and purified with a QIAquick nucleotide removal kit (QIAGEN). Fluorescent thiol (CM-SH) was prepared as described previously. S8 Fluorescent azide (Cy3-N3) was purchased from Jena Bioscience. Samples were concentrated on a CentriVap Vacuum Concentrator system (Labconco). Fluorescence spectra were measured on a Fluoromax 4 spectrofluorimeter (HORIBA Scientific).
Thiol additions to vinyl modified DNA
Vinyl modified DNA (DNA1 V A or DNA4 V A; 0.2 nmol) was dissolved in H2O (5 μl). To this thiol (CM-SH, 50 mM in H2O:DMSO = 2:1, 100 mM Et3N, 50 μl) was added and the reaction mixture was kept at 37 °C and 500 rpm for 3 days. For steady-state fluorescence measurements the product of thiol-ene addition was purified with QIAquick nucleotide removal kit (QIAGEN). Concentration of DNA was determined on a Nanodrop and recalculated using values from OligoCalc, S7 samples were concentrated. Concentration of DNA was adjusted to 1 μM in miliQ H2O. Emission spectra were recorded using a 100 μl quartz cuvette in phosphate buffer (20 mM, pH = 7.0, 1 M NaCl) by adding 10 μl of DNA solution; solution was mixed carefully with a pipete and equilibrated for 2 min in a thermal holder (25 °C) before the fluorescence spectrum was recorded. Excitation wavelength for DNAX CM A was 355 nm. Control experiments were performed using natural non-modified DNA following the same procedure. To obtain single-stranded DNA for MALDI analysis, the reaction was performed as described above using DNA after PEX with biotinylated template. The reaction mixture was diluted to a total volume of 200 μl with binding buffer (10 mM Tris, 1 mM EDTA, 100 mM NaCl, pH 7.5). Streptavidine magnetic particles (Roche, 200 μl) were washed with binding buffer (3  250 μl). The diluted click reaction (200 μl) was then added to magnetic particles. Mixture was incubated at 15 °C and 1100 rpm for 30 min. The magnetic beads were collected on a magnet (DynaMagTM-2, Invitrogen) and washed with washing buffer (3  250 μl, 10 mM Tris, 1 mM EDTA, 500 mM NaCl, pH 7.5) and water (5  250 μl). Then water (50 μl) was added and the sample was denatured for 2 min at 55 °C and 900 rpm. The beads were collected on a magnet and the solution was transferred into a clean vial and analyzed by MALDI-TOF MS (for copies of mass spectra see Figures S15 -S17) . To analyze the product of thiol-ene reaction using PAGE, the reaction was performed as described above using DNA after PEX with prim 248short -FAM and temp oligo1A
. The product of thiol-ene reaction was purified with QIAquick nucleotide removal kit (QIAGEN). Concentration of DNA was determined on a Nanodrop and recalculated using values from OligoCalc, S7 concentration of DNA was adjusted to 150 nM with miliQ water: PAGE stop solution (1:2). Aliquots (5 μl) were subjected to vertical electrophoresis in 12.5% denaturing polyacrylamide gel containing 1TBE buffer (pH 8.0) and 7 M urea at 42 mA for 75 min. The gel was visualized by a fluorescent scanner. Conversion of the reaction was determined using ImageJ software.
S9
Thermal denaturation studies
The oligonucleotides for these experiments were prepared by PEX on a large scale with KOD XL DNA polymerase and templates temp oligo1A or temp Prb4basII and primer prim 248short . Alternatively the oligonucleotides were prepared by post-synthetic modification of DNA1 V A or DNA1 E A by fluorescent labels. Concentration of DNA was determined on a Nanodrop and recalculated using values from OligoCalc. S7 Samples were concentrated and then redissolved in phosphate buffer (20 mM, pH = 7.0, 1 M NaCl) to have A260 approximately 0.1. Thermal denaturation studies were performed on a Cary 100 UV-Vis spectrometer equipped with temperature controller (Agilent Technologies). Data were collected from 6 independent heating-cooling cycles. Annealing temperatures (Tm / °C) were obtained by plotting temperature versus absorbance and applying a sigmodial curve fit. 
Copies of mass spectra
S28
Figure S19: MALDI-TOF MS spectrum of ON4 Cy3 A after CuAAC reaction of DNA4 E A with Cy3-N3, calculated for [M+H] + : 11868.0 Da; found: 11865.9 Da; the peak at m/z = 11537.3 can be assigned to ssDNA one nucleotide shorter after CuAAC reaction; missing peak at 9713.0 Da indicates full conversion of the reaction.
